GenMont Biotech (TPE:3164) Ending Cash Position : NT$110.5 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is GenMont Biotech Ending Cash Position?

GenMont Biotech's Ending Cash Position for the quarter that ended in Dec. 2024 was NT$110.5 Mil.

GenMont Biotech's quarterly Ending Cash Position declined from Jun. 2024 (NT$125.1 Mil) to Sep. 2024 (NT$85.5 Mil) but then increased from Sep. 2024 (NT$85.5 Mil) to Dec. 2024 (NT$110.5 Mil).

GenMont Biotech's annual Ending Cash Position declined from Dec. 2022 (NT$133.7 Mil) to Dec. 2023 (NT$55.6 Mil) but then increased from Dec. 2023 (NT$55.6 Mil) to Dec. 2024 (NT$110.5 Mil).

GenMont Biotech Ending Cash Position Historical Data

The historical data trend for GenMont Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GenMont Biotech Ending Cash Position Chart

GenMont Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

274.85

169.95

133.69

55.60

110.51

GenMont Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															55.60	93.25	125.11	85.49	110.51

GenMont Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GenMont Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	55.595	+	54.918
	=	110.5

GenMont Biotech's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	85.486	+	25.027
	=	110.5

GenMont Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GenMont Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GenMont Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GenMont Biotech Inc (TPE:3164) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741

Website

https://www.genmont.com.tw

GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements.

GenMont Biotech Headlines

No Headlines